Vasodilatory Shock
📧 Sign up to get email alerts when something new happens for Vasodilatory Shock.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-07-02Clinical Trial Results: Serum Biomarkers to Predict Response to Angiotensin II in Septic Shock [Phase 4]
Phase 4 trial evaluating serum biomarkers to predict response to Angiotensin II in septic shock; results completed and posted.
-
CLINICAL_TRIALS trial_result · 2026-02-05Clinical Trial Update: Serum Biomarkers to Predict Response to Angiotensin II in Septic Shock [Phase 4]
A Phase 4 clinical trial update reports on serum biomarkers to predict response to Angiotensin II in septic shock, and notes the trial statu…
-
CLINICAL_TRIALS trial_result · 2025-10-08Clinical Trial Update: Synthetic Angiotensin II/Giapreza in Pediatric Patients With Refractory Hypotension [Phase 4]
Phase 4 clinical trial evaluating synthetic angiotensin II (Giapreza) in pediatric patients with refractory hypotension (vasodilatory shock)…
-
FDA approval · 2025-06-03FDA Approved: ANGIOTENSIN II — Original Application (Gland Pharma Limited)
FDA approved Gland Pharma Limited's Angiotensin II under an Original Application (ANDA216966).
-
CLINICAL_TRIALS trial_result · 2025-05-01Clinical Trial Update: Vasopressin Use in Septic Shock From Türkiye
This document reports a completed clinical trial from Türkiye evaluating the use of vasopressin in septic shock.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-01-23Clinical Trial Update: Efficacy and Safety of Angiotensin II Injection Versus Placebo in Patients With Refractory Distributed Shock [Phase 3]
Phase 3 trial evaluating the efficacy and safety of angiotensin II injection versus placebo in patients with refractory vasodilatory shock; …
-
FDA approval · 2024-07-11FDA Approved: VASOPRESSIN IN 0.9% SODIUM CHLORIDE — Original Application (Long Grove Pharmaceuticals, LLC)
FDA approved VASOPRESSIN IN 0.9% SODIUM CHLORIDE from Long Grove Pharmaceuticals as an original NDA for vasopressin injection to be used as …
-
FDA approval · 2024-02-09FDA Approved: VASOPRESSIN — Original Application (Sagent Pharmaceuticals)
FDA approved the original application for a generic vasopressin product from Sagent Pharmaceuticals.
-
FDA approval · 2023-09-29FDA Approved: VASOPRESSIN IN 0.9% SODIUM CHLORIDE — Original Application (Baxter Healthcare Corporation)
The FDA granted approval for Baxter’s vasopressin in 0.9% sodium chloride under an Original Application (NDA).
-
FDA approval · 2023-07-21FDA Approved: VASOPRESSIN — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approves Amneal's supplemental application for Vasopressin under ANDA212944, authorizing changes to the approved generic product.
-
FDA approval · 2022-08-15FDA Approved: VASOPRESSIN — Original Application (Eugia US LLC)
FDA approved the original application for VASOPRESSIN from Eugia US LLC, a generic vasopressin product. It is indicated for use as a vasopre…
-
FDA approval · 2021-03-15FDA Approved: VASOSTRICT — Supplemental Application (Par Health USA, LLC)
FDA approved a supplemental application for Vasostrict (vasopressin) submitted by Par Health USA, LLC.
-
CLINICAL_TRIALS approval · 2018-03-08Clinical Trial Update: Expanded Access for LJPC-501
La Jolla Pharmaceutical Company's LJPC-501 has been approved for marketing to treat catecholamine-resistant hypotension and distributive sho…
-
FDA approval · 2016-12-17FDA Approved: VASOSTRICT — Supplemental Application (Par Health USA, LLC)
FDA approved a supplemental application for Vasostrict (vasopressin) submitted by Par Health USA, LLC. This action concerns the approval of …
-
FDA approval · 2014-04-17FDA Approved: VASOSTRICT — Original Application (Par Health USA, LLC)
The FDA granted approval for VASOSTRICT (vasopressin) through an Original Application from Par Health USA, LLC. It is approved as a vasopres…